Development of an Advanced Multicellular Intestinal Model for Assessing Immunomodulatory Properties of Anti-Inflammatory Compounds
Diego Marescotti(Philip Morris International (Switzerland)), Julia Hoeng(Philip Morris International (Switzerland)), Manuel C. Peitsch(Philip Morris International (Switzerland)), Romain Piault(Philip Morris International (Switzerland)), Fabian Moine(Philip Morris International (Switzerland)), Diego Guerrera(Philip Morris International (Switzerland)), Pedro A. Ruiz(University of Zurich), Stefan Frentzel(Philip Morris International (Switzerland)), Giuseppe Lo Sasso(Philip Morris International (Switzerland)), Kasper Renggli(Vectura (Germany)), Vincent Jaquet(University of Geneva), Karsta Luettich(Philip Morris International (Switzerland))
Cited by 24
Related Papers
Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome
|Gut|2016|318
Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation
|Nature Communications|2017|312
Selective and Responsive Nanoreactors
|Advanced Functional Materials|2011|231
A lung/liver-on-a-chip platform for acute and chronic toxicity studies
|Lab on a Chip|2018|182
Protein cages and synthetic polymers: a fruitful symbiosis for drug delivery applications, bionanotechnology and materials science
|Chemical Society Reviews|2016|174